Evaluation and Treatment of Hepatitis C

Charitha Gowda, MD, MPH, Infectious diseases physician at Penn Presbyterian Medical Center explains the process for the evaluation of hepatitis C, leading up to treatment.

Charitha Gowda, MD, MPH, Infectious diseases physician at Penn Presbyterian Medical Center explains the process for the evaluation of hepatitis C, leading up to treatment.

Related Videos
Related Content

Antiviral in Development for COVID-19 and HCV Treatment

June 1st 2023

World Hepatitis Day: Where Do We Go From Here?

July 28th 2022

Xacduro, A New Weapon in the Fight Against Bacterial Pneumonia: Insights From Clinical Trials and Expert Interviews

May 26th 2023

“We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs

March 18th 2022

Hepatitis C Virus Disproportionately Affects Immigrants, Study Finds

May 24th 2023

FDA Approves Sulbactam-Durlobactam for Bacterial Pneumonia

May 23rd 2023

Antiviral in Development for COVID-19 and HCV Treatment

June 1st 2023

World Hepatitis Day: Where Do We Go From Here?

July 28th 2022

Xacduro, A New Weapon in the Fight Against Bacterial Pneumonia: Insights From Clinical Trials and Expert Interviews

May 26th 2023

“We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs

March 18th 2022

Hepatitis C Virus Disproportionately Affects Immigrants, Study Finds

May 24th 2023

FDA Approves Sulbactam-Durlobactam for Bacterial Pneumonia

May 23rd 2023

Antiviral in Development for COVID-19 and HCV Treatment

June 1st 2023

World Hepatitis Day: Where Do We Go From Here?

July 28th 2022

Xacduro, A New Weapon in the Fight Against Bacterial Pneumonia: Insights From Clinical Trials and Expert Interviews

May 26th 2023

“We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs

March 18th 2022

Hepatitis C Virus Disproportionately Affects Immigrants, Study Finds

May 24th 2023

FDA Approves Sulbactam-Durlobactam for Bacterial Pneumonia

May 23rd 2023
© 2023 MJH Life Sciences

All rights reserved.